Additional file 2: Table S1. of Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis

Buysman, Erin; Chow, Wing; Henk, Henry; Rupnow, Marcia

doi:10.6084/m9.figshare.c.3645332_D1.v1

12902_2015_64_MOESM2_ESM.doc (36.5 kB)

Additional file 2: Table S1. of Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis

journal contribution

posted on 2015-11-02, 05:00 authored by Erin Buysman, Wing Chow, Henry Henk, Marcia Rupnow

Baseline characteristics of patients with T2DM with baseline and follow-up A1C measurements treated with canagliflozin. A1C, glycated hemoglobin; DCSI, diabetes complication severity index; OB/GYM, obstetric/gynecology; SD, standard deviation. (DOC 36 kb)